Your browser doesn't support javascript.
loading
Erratum to: Japanese phase II study of rituximab maintenance for untreated indolent B-cell non-Hodgkin lymphoma with high tumor burden.
Igarashi, Tadahiko; Ogura, Michinori; Itoh, Kuniaki; Taniwaki, Masafumi; Ando, Kiyoshi; Kuroda, Yoshiaki; Yamamoto, Kazuhito; Uike, Naokuni; Tomita, Akihiro; Nagai, Hirokazu; Kurosawa, Mitsutoshi; Mori, Shigeo; Nawano, Shigeru; Terauchi, Takashi; Ohashi, Yasuo; Tobinai, Kensei.
Afiliação
  • Igarashi T; Division of Hematology/Oncology, Gunma Cancer Center, 617-1 Takabayashinishicho, Ohta, 373-8550, Japan. taigarash@gunma-cc.jp.
  • Ogura M; Department of Hematology and Oncology, Nagoya Daini Red Cross Hospital, Nagoya, Japan.
  • Itoh K; Department of Hematology, Tokai Central Hospital, Kakamigahara, Japan.
  • Taniwaki M; Department of Hematology, National Cancer Center Hospital East, Chiba, Japan.
  • Ando K; Department of Hematology, Kyoto Prefectural University of Medicine, Kyoto, Japan.
  • Kuroda Y; Department of Hematology/Oncology, Tokai University School of Medicine, Kanagawa, Japan.
  • Yamamoto K; Department of Hematology, Hiroshima University School of Medicine, Hiroshima, Japan.
  • Uike N; Division of Stem Cell Regulation, Center for Molecular Medicine, Jichi Medical University, Tochigi, Japan.
  • Tomita A; Department of Hematology and Cell Therapy, Aichi Cancer Center Hospital, Nagoya, Japan.
  • Nagai H; Department of Hematology, National Hospital Organization, Kyushu Cancer Center, Fukuoka, Japan.
  • Kurosawa M; Department of Palliative Care, Saga Prefectural Hospital Koseikan, Saga, Japan.
  • Mori S; Department of Hematology and Oncology, Nagoya University Graduate School of Medicine, Nagoya, Japan.
  • Nawano S; Department of Hematology, Fujita Health University School of Medicine, Toyoake, Japan.
  • Terauchi T; Department of Hematology, National Hospital Organization, Nagoya Medical Center, Nagoya, Japan.
  • Ohashi Y; Department of Hematology, National Hospital Organization, Hokkaido Cancer Center, Sapporo, Japan.
  • Tobinai K; The University of Tokyo, Tokyo, Japan.
Int J Hematol ; 105(1): 109-110, 2017 Jan.
Article em En | MEDLINE | ID: mdl-27896571

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Idioma: En Revista: Int J Hematol Assunto da revista: HEMATOLOGIA Ano de publicação: 2017 Tipo de documento: Article País de afiliação: Japão